Target
Envelope glycoprotein gp160 [V370A]
Ligand
BDBM271391
Substrate
n/a
Meas. Tech.
MT4 Cell Antiviral Assay
EC50
14.3±n/a nM
Citation
 Johns, BA Compounds and compositions for treating HIV with derivatives of Betulin US Patent  US10064873 Publication Date 9/4/2018 
Target
Name:
Envelope glycoprotein gp160 [V370A]
Synonyms:
Envelope glycoprotein gp160 (V370A) | NL4-3 (V370A) | Q72502_9HIV1 | env
Type:
Enzyme Catalytic Domain
Mol. Mass.:
97003.09
Organism:
Human immunodeficiency virus 1
Description:
Q72502[V370A]
Residue:
854
Sequence:
MRVKEKYQHLWRWGWKWGTMLLGILMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKAYDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKDDMVEQMHEDIISLWDQSLKPCVKLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRDKVQKEYAFFYKLDIVPIDNTSYRLISCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEDVVIRSANFTDNAKTIIVQLNTSVEINCTRPNNNTRKSIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIASKLREQFGNNKTIIFKQSSGGDPEIATHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRIKQFINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSDIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPLSFQTHLPIPRGPDRPEGIEEEGGERGRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYWSQELKNSAVNLLNATAIAVAEGTDRVIEVLQAAYRAIRHIPRRIRQGLERILL
  
Inhibitor
Name:
BDBM271391
Synonyms:
4- {[(1R,2R,5R,10S,13R,14R, 17S,19R)-5-(2-{[(3- chloro-2- fluorophenyl)methyl]amino} ethyl)-1,2,14,18,18- pentamethyl-7-oxo-8- (propan-2- yl)pentacyclo[11.8.0.0{circumflex over ()} {2,10}.0{circumflex over ()}{5,9}.0{circumflex over ()}{14,19}] henicos-8-en-17-yl]oxy}- 2,2-dimethyl-4- oxobutanoic acid | US10064873, Example 8
Type:
Small organic molecule
Emp. Form.:
C44H63ClFNO5
Mol. Mass.:
740.426
SMILES:
[H][C@]12CC[C@]3([H])[C@@]4(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC[C@@]1(CCNCc3cccc(Cl)c3F)CC(=O)C(C(C)C)=C21 |r,t:57|
Structure:
Search PDB for entries with ligand similarity: